2012 Rhode Island State Health Lab FDA/FERN Microbiology Cooperative Agreement

项目摘要 罗得岛州卫生实验室（RISHL）是FERN的成员，因此， 致力于做好检测和应对食源性疾病暴发的准备。的 实验室寻求保持能力，通过参与第一个周期， 微生物学合作协议计划（FDA/FERN MCAP），通过续 参与MCAP。有了这个延续奖的支持，RISHL将 保持一个工作人员培训的各种设备平台和协议规定的 FDA和FERN将参与方法开发和能力验证， 为FDA食品检测提供激增能力，并将同意与 FDA / FERN通过eLEXNET。

Project Summary The Rhode Island State Health Laboratory (RISHL) is a member of the FERN and as such, is committed to preparedness for detection and response to foodborne disease outbreaks. The laboratory seeks to maintain capability, augmented through participation in the first cycle of Microbiology Cooperative Agreement Program (FDA/FERN MCAP), through continued participation in the MCAP. With the support of this continuation award, the RISHL will maintain a staff trained on a variety of equipment platforms and protocols specified by the FDA and FERN, will participate in methods development and proficiency testing, will provide surge capacity for FDA food testing, and will agree to share all testing results with FDA / FERN through eLEXNET.